Literature DB >> 21566127

Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L.

Renata Z Jurkowska1, Arumugam Rajavelu, Nils Anspach, Claus Urbanke, Gytis Jankevicius, Sergey Ragozin, Wolfgang Nellen, Albert Jeltsch.   

Abstract

Structural studies showed that Dnmt3a has two interfaces for protein-protein interaction in the heterotetrameric Dnmt3a/3L C-terminal domain complex: the RD interface (mediating the Dnmt3a-3a contact) and the FF interface (mediating the Dnmt3a-3L contact). Here, we demonstrate that Dnmt3a-C forms dimers via the FF interface as well, which further oligomerize via their RD interfaces. Each RD interface of the Dnmt3a-C oligomer creates an independent DNA binding site, which allows for binding of separate DNA molecules oriented in parallel. Because Dnmt3L does not have an RD interface, it prevents Dnmt3a oligomerization and binding of more than one DNA molecule. Both interfaces of Dnmt3a are necessary for the heterochromatic localization of the enzyme in cells. Overexpression of Dnmt3L in cells leads to the release of Dnmt3a from heterochromatic regions, which may increase its activity for methylation of euchromatic targets like the differentially methylated regions involved in imprinting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566127      PMCID: PMC3129201          DOI: 10.1074/jbc.M111.254987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog.

Authors:  Jing-Yu Li; Min-Tie Pu; Ryutaro Hirasawa; Bin-Zhong Li; Yan-Nv Huang; Rong Zeng; Nai-He Jing; Taiping Chen; En Li; Hiroyuki Sasaki; Guo-Liang Xu
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 2.  DNA methylation: the nuts and bolts of repression.

Authors:  Tina Branscombe Miranda; Peter A Jones
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 3.  A mechanistic view of genomic imprinting.

Authors:  Ky Sha
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

Review 4.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 5.  Cancer epigenomics: DNA methylomes and histone-modification maps.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2007-03-06       Impact factor: 53.242

6.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation.

Authors:  Da Jia; Renata Z Jurkowska; Xing Zhang; Albert Jeltsch; Xiaodong Cheng
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

7.  A cross-species comparison of X-chromosome inactivation in Eutheria.

Authors:  Ziny C Yen; Irmtraud M Meyer; Sanja Karalic; Carolyn J Brown
Journal:  Genomics       Date:  2007-08-28       Impact factor: 5.736

Review 8.  Mammalian DNA methyltransferases: a structural perspective.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

Review 9.  Construction and evolution of imprinted loci in mammals.

Authors:  Timothy A Hore; Robert W Rapkins; Jennifer A Marshall Graves
Journal:  Trends Genet       Date:  2007-08-01       Impact factor: 11.639

10.  Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice.

Authors:  G Howard; R Eiges; F Gaudet; R Jaenisch; A Eden
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

View more
  43 in total

1.  Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.

Authors:  Celeste Holz-Schietinger; Doug M Matje; Norbert O Reich
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

2.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

3.  DNA methylation: a new twist in the tail.

Authors:  Gavin Kelsey
Journal:  Cell Res       Date:  2011-07-05       Impact factor: 25.617

Review 4.  Epigenetics and Bone Remodeling.

Authors:  Ali Husain; Matlock A Jeffries
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

5.  Cooperative DNA binding and protein/DNA fiber formation increases the activity of the Dnmt3a DNA methyltransferase.

Authors:  Max Emperle; Arumugam Rajavelu; Richard Reinhardt; Renata Z Jurkowska; Albert Jeltsch
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

Review 6.  The de novo DNA methyltransferase DNMT3A in development and cancer.

Authors:  Bi-Feng Chen; Wai-Yee Chan
Journal:  Epigenetics       Date:  2014-03-03       Impact factor: 4.528

7.  Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression.

Authors:  Jie Lu; Monika Mccarter; Gewei Lian; Giuseppe Esposito; Elena Capoccia; Laurent C Delli-Bovi; Jonathan Hecht; Volney Sheen
Journal:  Hum Mol Genet       Date:  2016-02-23       Impact factor: 6.150

Review 8.  Heterochromatin and the molecular mechanisms of 'parent-of-origin' effects in animals.

Authors:  Prim B Singh
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

Review 9.  Insight into the cooperative DNA binding of the O⁶-alkylguanine DNA alkyltransferase.

Authors:  Ingrid Tessmer; Michael G Fried
Journal:  DNA Repair (Amst)       Date:  2014-02-16

10.  The UHRF1 protein stimulates the activity and specificity of the maintenance DNA methyltransferase DNMT1 by an allosteric mechanism.

Authors:  Pavel Bashtrykov; Gytis Jankevicius; Renata Z Jurkowska; Sergey Ragozin; Albert Jeltsch
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.